← Leaderboards
Un Jung Kang
University Of Chicago
$14,481,465
Attributed
$14,714,527
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,714,527 · 13
By mechanism
R01$12,085,890 · 7
R21$1,387,125 · 3
R56$1,081,512 · 2
R03$160,000 · 1
Top collaborators
- Nicolas Xavier Tritsch2 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Eric C Beyer$20,572,313
- Viviana M Berthoud Barrandeguy$1,075,060
- Ying-Wan Lam$153,688
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsParkinson DiseaseDopamineMotorResponseMediatingDopaminergic NeuronPathway InteractionsCorpus Striatum StructureMouse ModelFunctional DisorderBasePreventBehavioralBasal GangliaAttenuatedLevodopaBehaviorChronicLeadCellsL-Dopa Induced DyskinesiaDyskinetic SyndromeLesion
Grant awards (46)
Single Cell Transcriptomic Profiling of Multiple System Atrophy Brain$650,589
R01 · FY2025 · NS · contact PI
Circuit Mechanisms of Bradykinesia in Mouse Models of Parkinsonâs Disease$211,875
R21 · FY2025 · NS · contact PI
Single Cell Transcriptomic Profiling of Multiple System Atrophy Brain$666,123
R01 · FY2024 · NS · contact PI
Neural Substrates of the long-duration response$466,125
R21 · FY2024 · NS · contact PI
Circuit Mechanisms of Bradykinesia in Mouse Models of Parkinsonâs Disease$254,250
R21 · FY2024 · NS · contact PI
Single Cell Transcriptomic Profiling of Multiple System Atrophy Brain$593,250
R56 · FY2023 · NS · contact PI
Pathological striatopallidal neuronalensembles in learned motor impairment in PD$370,781
R01 · FY2022 · NS · contact PI
Pathological striatopallidal neuronalensembles in learned motor impairment in PD$370,781
R01 · FY2021 · NS · contact PI
The striatal cholinergic interneurons in Parkinson's disease and treatment$462,557
R01 · FY2020 · NS · contact PI
Pathological striatopallidal neuronalensembles in learned motor impairment in PD$370,781
R01 · FY2020 · NS · contact PI
The striatal cholinergic interneurons in Parkinson's disease and treatment$492,294
R01 · FY2019 · NS · contact PI
Pathological striatopallidal neuronalensembles in learned motor impairment in PD$370,781
R01 · FY2019 · NS · contact PI
Regulation of L-DOPA induced dyskinesia by the substantia nigra pars reticulata$211,875
R21 · FY2019 · NS · contact PI
The striatal cholinergic interneurons in Parkinson's disease and treatment$455,112
R01 · FY2018 · NS · contact PI
Pathological striatopallidal neuronalensembles in learned motor impairment in PD$354,375
R01 · FY2018 · NS · contact PI
Regulation of L-DOPA induced dyskinesia by the substantia nigra pars reticulata$203,773
R21 · FY2018 · NS · contact PI
Regulation of L-DOPA induced dyskinesia by the substantia nigra pars reticulata$39,227
R21 · FY2018 · NS · contact PI
The striatal cholinergic interneurons in Parkinson's disease and treatment$396,336
R01 · FY2017 · NS · contact PI
Plasticity of bridge collaterals in Parkinonian state and treatment$80,000
R03 · FY2017 · NS · contact PI
The role of striatal cholinergic interneurons in Parkinsonâs disease$488,262
R56 · FY2016 · NS · contact PI
Plasticity of bridge collaterals in Parkinonian state and treatment$80,000
R03 · FY2016 · NS · contact PI
Striatal cholinergic neurons and L-DOPA induced dyskinesia$283,940
R01 · FY2013 · NS · contact PI
Striatal cholinergic neurons and L-DOPA induced dyskinesia$38,780
R01 · FY2013 · NS · contact PI
Striatal cholinergic neurons and L-DOPA induced dyskinesia$334,425
R01 · FY2012 · NS · contact PI
Striatal cholinergic neurons and L-DOPA induced dyskinesia$334,425
R01 · FY2011 · NS · contact PI
Neuroprotective mechanism of DJ-1 in Parkinson's disease$329,066
R01 · FY2011 · NS · contact PI
Neuroprotective mechanism of DJ-1 in Parkinson's disease$391,493
R01 · FY2010 · NS · contact PI
Striatal cholinergic neurons and L-DOPA induced dyskinesia$337,838
R01 · FY2010 · NS · contact PI
Neuroprotective mechanism of DJ-1 in Parkinson's disease$394,977
R01 · FY2009 · NS · contact PI
Striatal cholinergic neurons and L-DOPA induced dyskinesia$341,250
R01 · FY2009 · NS · contact PI
Neuroprotective mechanism of DJ-1 in Parkinson's disease$21,600
R01 · FY2009 · NS · contact PI
Neuroprotective mechanism of DJ-1 in Parkinson's disease$335,781
R01 · FY2008 · NS · contact PI
Neuroprotective mechanism of DJ-1 in Parkinson's disease$48,958
R01 · FY2008 · NS · contact PI
Neuroprotective mechanism of DJ-1 in Parkinson's disease$335,781
R01 · FY2007 · NS · contact PI
The neuroprotective effect of tetrahydrobiopterin$326,898
R01 · FY2007 · NS · contact PI
The neuroprotective effect of tetrahydrobiopterin$337,157
R01 · FY2006 · NS · contact PI
Dopamine regulation in parkinsonian rat by gene therapy$318,309
R01 · FY2006 · NS · contact PI
The neuroprotective effect of tetrahydrobiopterin$345,763
R01 · FY2005 · NS
Dopamine regulation in parkinsonian rat by gene therapy$325,969
R01 · FY2005 · NS
The neuroprotective effect of tetrahydrobiopterin$346,242
R01 · FY2004 · NS
Dopamine regulation in parkinsonian rat by gene therapy$325,969
R01 · FY2004 · NS
The neuroprotective effect of tetrahydrobiopterin$346,690
R01 · FY2003 · NS
Dopamine regulation in parkinsonian rat by gene therapy$325,969
R01 · FY2003 · NS
Dopamine regulation in parkinsonian rat by gene therapy$325,167
R01 · FY2002 · NS
CATECHOLAMINE REGULATION IN GENETICALLY MODIFIED GRAFTS$49,965
R01 · FY2001 · NS
CATECHOLAMINE REGULATION IN GENETICALLY MODIFIED GRAFTS$222,968
R01 · FY2000 · NS